Wednesday, November 1, 2017

Another Alzheimer Drug Bites the Dust

Another potential blockbuster drug has flopped. Despite this,  the feds still have natural alternative treatments in the crosshairs.

From Forbes:

Investors poured hundreds of millions of dollars into Axovant and its experimental Alzheimer’s drug, intepirdine. But in the end, the medicine was no different from 99% of medicines tested against the brain-wasting disease since 2002 — it failed.

Comment: This just the latest failure from Big Pharma to develop a viable Alzheimer’s drug. Meanwhile, their friends at the FDA seek to clear natural alternatives like vinpocetine from the market. (And, recall our previous coverage of the promise coconut oil shows in fighting Alzheimer’s.) With synthetic drugs failing to deliver, the trend is to try and turn natural medicine into drugs and have the FDA eliminate the affordable supplement versions from store shelves—see Amarin’s latest effort to ban fish oil imports.

from The Alliance for Natural Health http://ift.tt/2gUIuw2 via Aloe for Health




from http://ift.tt/2zpJEeb

Another Alzheimer Drug Bites the Dust

Another potential blockbuster drug has flopped. Despite this,  the feds still have natural alternative treatments in the crosshairs.

From Forbes:

Investors poured hundreds of millions of dollars into Axovant and its experimental Alzheimer’s drug, intepirdine. But in the end, the medicine was no different from 99% of medicines tested against the brain-wasting disease since 2002 — it failed.

Comment: This just the latest failure from Big Pharma to develop a viable Alzheimer’s drug. Meanwhile, their friends at the FDA seek to clear natural alternatives like vinpocetine from the market. (And, recall our previous coverage of the promise coconut oil shows in fighting Alzheimer’s.) With synthetic drugs failing to deliver, the trend is to try and turn natural medicine into drugs and have the FDA eliminate the affordable supplement versions from store shelves—see Amarin’s latest effort to ban fish oil imports.



from The Alliance for Natural Health http://ift.tt/2gUIuw2 via Aloe for Health
from Tumblr http://ift.tt/2h4YLCe

Tuesday, October 31, 2017

Sit Down and Eat Your GMOs

Consumers are targeted by the FDA’s newest GMO propaganda campaign.

From the FDA:

The U.S Food and Drug Administration is announcing public meetings to be held in Charlotte, North Carolina, and San Francisco, California, regarding its Agricultural Biotechnology Education and Outreach Initiative. Congress appropriated $3 million to fund this initiative, which calls upon the FDA to work with USDA to provide education and outreach to the public on agricultural biotechnology and food and animal feed ingredients derived from biotechnology.

The purpose of the public meetings is to provide the public with an opportunity to share information, experiences, and suggestions to help inform the development of this education and outreach initiative.

Comment: From the same Congress that gave you the sham GMO “labeling” bill comes a taxpayer-funded propaganda campaign on behalf of the biotech industry to convince you that GMOs are perfectly safe. Now, the FDA wants your advice on how they can best “educate” US citizens on the many virtues of GMO food.

Check out our GMO Fact Check page for a much more accurate education about GMO foods.

from The Alliance for Natural Health http://ift.tt/2A4OIla via Aloe for Health




from http://ift.tt/2A3YV1w

Sit Down and Eat Your GMOs

Consumers are targeted by the FDA’s newest GMO propaganda campaign.

From the FDA:

The U.S Food and Drug Administration is announcing public meetings to be held in Charlotte, North Carolina, and San Francisco, California, regarding its Agricultural Biotechnology Education and Outreach Initiative. Congress appropriated $3 million to fund this initiative, which calls upon the FDA to work with USDA to provide education and outreach to the public on agricultural biotechnology and food and animal feed ingredients derived from biotechnology.

The purpose of the public meetings is to provide the public with an opportunity to share information, experiences, and suggestions to help inform the development of this education and outreach initiative.

Comment: From the same Congress that gave you the sham GMO “labeling” bill comes a taxpayer-funded propaganda campaign on behalf of the biotech industry to convince you that GMOs are perfectly safe. Now, the FDA wants your advice on how they can best “educate” US citizens on the many virtues of GMO food.

Check out our GMO Fact Check page for a much more accurate education about GMO foods.



from The Alliance for Natural Health http://ift.tt/2A4OIla via Aloe for Health
from Tumblr http://ift.tt/2iRRuGj

Wednesday, October 25, 2017

Will Dying People Get The Right to Try?

Legislation, approved in the Senate, must now pass the House of Representatives. Action Alert!

Earlier this year, the “Right to Try” legislation introduced by Sen. Ron Johnson (R-WI) passed by unanimous consent in the Senate. It had a hearing last week in the House, and awaits approval.

As things stand now, FDA bureaucrats continue to throw roadblocks into the path of patients who desire access to experimental and potentially life-saving drugs, as the agency has been doing for years. This is yet another example of why we feel the agency works for Big Pharma more than for the American people.

Here’s how it works—or rather, doesn’t work—currently. Individual patients may apply for access to experimental treatments outside of a drug trial if they meet all three of the following criteria:

  • have a serious or life-threatening disease or condition;
  • have no other treatment options left; and
  • can persuade a qualified physician to deliver the treatment.

Under these circumstances, the FDA may, at its sole discretion, grant “compassionate use” of the new or unapproved medication. But the program is marred by a prohibitively cumbersome application and documentation process, which always makes it difficult and sometimes drags it out or otherwise makes it impossible. In addition, a physician cooperating with the patient may put his or her license at risk.  The agency can even revoke permission after it has been granted—and does.

The government has no business intervening in a patient’s life in this manner. Decisions that are made when a patient is terminally ill should be between the patient, his or her doctor, and his or her family—not FDA bureaucrats.

Action Alert! Write to your representative and urge him or her to support Right to Try legislation. Please send your message immediately.

 

from The Alliance for Natural Health http://ift.tt/2i4f7Yq via Aloe for Health




from http://ift.tt/2zPSIpO